Related articles:

Argos Therapeutics Inc.: Argos Therapeutics to Participate in BIO CEO and Investor Conference
February 06, 2017

Argos Therapeutics Inc.: Argos Therapeutics Completes Lease Agreement for Commercial Manufacturing Space on the Centennial Campus of North Carolina State University
January 19, 2017

Argos Therapeutics Inc.: Argos Therapeutics Announces CEO Jeff Abbey Elected to NCBIO Board of Directors
October 26, 2016

Argos Therapeutics Inc.: Argos Therapeutics Reports Second Quarter 2016 Financial Results and Recent Operational Highlights
August 10, 2016

Argos Therapeutics Inc.: Argos Therapeutics to Host Second Quarter 2016 Financial Results Conference Call on Wednesday, August 10, 2016
August 04, 2016

Argos Therapeutics Inc.: Dr. Richard D. Katz Joins Argos Therapeutics as Chief Financial Officer
July 11, 2016

Argos Therapeutics Inc.: Argos Therapeutics Enters into Strategic Research Agreement with Adaptive Biotechnologies
June 15, 2016

Argos Therapeutics Inc.: Independent Data Monitoring Committee Recommends Continuation of ADAPT Phase 3 Clinical Trial of AGS-003 in Metastatic Renal Cell Carcinoma Following Interim Data Review
June 13, 2016

Argos Therapeutics Inc.: Argos Therapeutics Reports First Quarter 2016 Financial Results and Operational Highlights
May 12, 2016

Argos Therapeutics Inc.: Argos Therapeutics to Host First Quarter 2016 Financial Results Conference Call on Thursday, May 12, 2016
May 05, 2016

Argos Therapeutics Inc.: Argos Therapeutics Reports Fourth Quarter and Full-Year 2015 Financial Results and Operational Highlights
March 29, 2016

Argos Therapeutics Inc.: CORRECTION -- Argos Therapeutics Reports Fourth Quarter and Full-Year 2015 Financial Results and Operational Highlights
March 29, 2016

Argos Therapeutics Inc.: Argos Therapeutics to Host Fourth Quarter and Full-Year 2015 Financial Results Conference Call on Tuesday, March 29, 2016
March 22, 2016

Argos Therapeutics Inc.: Dr. Lee F. Allen Joins Argos Therapeutics as Chief Medical Officer
January 20, 2016

Argos Therapeutics Inc.: Argos Therapeutics Reports Third Quarter 2015 Financial Results and Operational Highlights
November 16, 2015

Argos Therapeutics Inc.: Argos Therapeutics to Host Third Quarter 2015 Financial Results Conference Call on Monday, November 16, 2015
November 09, 2015

Argos Therapeutics Inc.: Robert F. Carey Appointed to the Board of Directors of Argos Therapeutics
September 23, 2015

Argos Therapeutics Inc.: Argos Therapeutics Awarded Patent for Its Experimental Individualized Immunotherapy for the Treatment of HIV Infection
August 24, 2015

Argos Therapeutics Inc.: Argos Therapeutics Reports Second Quarter 2015 Financial Results and Operational Highlights
August 12, 2015

Argos Therapeutics Inc.: Argos Therapeutics to Hold Second Quarter 2015 Financial Results Conference Call on Wednesday, August 12, 2015
August 05, 2015

Argos Therapeutics Inc.: Argos Therapeutics Hires John D. Menditto as Vice President of Corporate Communications and Investor Relations
June 15, 2015

Argos Therapeutics Inc.: Argos Therapeutics Reports First Quarter 2015 Financial Results and Operational Highlights
May 14, 2015

Argos Therapeutics Inc.: Argos Therapeutics to Hold First Quarter 2015 Financial Results Conference Call on Thursday, May 14, 2015
May 07, 2015

Argos Therapeutics Inc.: Argos Therapeutics Reports Fourth Quarter and Year-End 2014 Financial Results
March 30, 2015

Argos Therapeutics Inc.: Argos Therapeutics to Hold Fourth Quarter and Year-End 2014 Financial Results Conference Call on Monday, March 30, 2015
March 16, 2015

Argos Therapeutics Inc.: Argos Therapeutics Reports Third Quarter 2014 Financial Results and Operational Highlights
November 13, 2014

Argos Therapeutics Inc.: Philippe Van Holle Joins Argos Therapeutics Board of Directors
November 13, 2014

Argos Therapeutics Inc.: Argos Therapeutics to Hold Third Quarter 2014 Financial Results Conference Call on Thursday, November 13, 2014
November 06, 2014

Argos Therapeutics Inc.: Argos Therapeutics Enters Into $25 Million Venture Loan Facility Led by Horizon Technology Finance
September 30, 2014

Argos Therapeutics Inc.: Argos Announces Issuance of Arcelis(R) Technology Platform Patent
September 08, 2014

Argos Therapeutics Inc.: Argos Therapeutics Reports Second Quarter 2014 Financial Results and Operational Highlights
August 13, 2014

Argos Therapeutics Inc.: Argos Therapeutics to Hold Second Quarter 2014 Financial Results Conference Call on Wednesday, August 13, 2014
August 06, 2014

Argos Therapeutics Inc.: Argos Therapeutics Reports First Quarter 2014 Financial Results
May 13, 2014

Argos Therapeutics Inc.: Argos Therapeutics to Hold First Quarter 2014 Financial Results Conference Call on Tuesday, May 13, 2014
April 29, 2014

Argos Therapeutics Inc.: Argos Therapeutics Announces Filing of Its Annual Report on Form 10-K
April 07, 2014

Argos Therapeutics Inc.: Argos Therapeutics Reports Fourth Quarter and Year-End 2013 Financial Results
March 27, 2014

Argos Therapeutics Inc.: Argos Therapeutics to Hold Fourth Quarter and Year End 2013 Financial Results Conference Call on Thursday, March 27, 2014
March 14, 2014

Argos Therapeutics Inc.: Argos Therapeutics Prices Initial Public Offering
February 07, 2014